These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 21828345

  • 1. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
    Novak J, Raskova Kafkova L, Suzuki H, Tomana M, Matousovic K, Brown R, Hall S, Sanders JT, Eison TM, Moldoveanu Z, Novak L, Novak Z, Mayne R, Julian BA, Mestecky J, Wyatt RJ.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3451-7. PubMed ID: 21828345
    [Abstract] [Full Text] [Related]

  • 2. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.
    Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
    [Abstract] [Full Text] [Related]

  • 3. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
    Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M.
    Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
    [Abstract] [Full Text] [Related]

  • 4. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC.
    Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891
    [Abstract] [Full Text] [Related]

  • 5. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 6. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Apr 05; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 7. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 05; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 8. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Apr 05; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 9. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 10. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 11. IL-6 and its role in IgA nephropathy development.
    Groza Y, Jemelkova J, Kafkova LR, Maly P, Raska M.
    Cytokine Growth Factor Rev; 2022 Aug 29; 66():1-14. PubMed ID: 35527168
    [Abstract] [Full Text] [Related]

  • 12. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 29; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 13. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 29; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 14. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.
    Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I.
    Int Immunol; 2012 Apr 29; 24(4):219-32. PubMed ID: 22298882
    [Abstract] [Full Text] [Related]

  • 15. The effect of IgA immune complexes on the proliferation of cultured human mesangial cells.
    Fujii K, Muller KD, Clarkson AR, Woodroffe AJ.
    Am J Kidney Dis; 1990 Sep 29; 16(3):207-10. PubMed ID: 2399913
    [Abstract] [Full Text] [Related]

  • 16. The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
    Schmitt R, Ståhl AL, Olin AI, Kristoffersson AC, Rebetz J, Novak J, Lindahl G, Karpman D.
    J Immunol; 2014 Jul 01; 193(1):317-26. PubMed ID: 24850720
    [Abstract] [Full Text] [Related]

  • 17. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 18. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan 13; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 19. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ, van Kooten C, de Fijter JW, Daha MR.
    Kidney Int; 2005 Mar 13; 67(3):813-21. PubMed ID: 15698421
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Mar 13; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.